Literature DB >> 14989494

An antigen unmasking protocol that satisfies both immunohistochemistry and subsequent PCR amplification.

Yan-Gao Man1, Ana Burgar.   

Abstract

Immunohistochemical elucidation of many proteins in formalin-fixed, paraffin-embedded tissues requires a prior antigen unmasking treatment, which often damages both the morphology and genetic materials, making subsequent assessments difficult or impossible. This study attempted to develop a method that satisfies both immunohistochemical and genetic analyses. Consecutive sections were made from formalin-fixed, paraffin-embedded breast and other tissues, and a set of four adjacent sections from each case were treated with (1) routine H & E staining; (2) our unmasking protocol; (3) microwave oven irradiation; (4) pressure cooker incubation. After immunohistochemical staining, the tissue in each section was scraped off, or the same cell clusters in four sections were separately microdissected for DNA extraction and PCR amplification. Compared to microwave and pressure cooker methods, our protocol showed the following advantages: (1) a better preservation of the morphology; (2) a substantial reduction of tissue detachments from slides; (3) effectiveness on all antibodies tested, including those requiring enzyme digestion or no prior unmasking; (4) higher PCR yields; (5) larger (higher molecular weight) amplified PCR products. Compared to the routine method on untreated tissues, our method consistently produced a comparable quality and quantity of PCR products. Our protocol, however, takes a longer time to yield results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14989494     DOI: 10.1078/0344-0338-00501

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  DNA and RNA isolated from tissues processed by microwave-accelerated apparatus MFX-800-3 are suitable for subsequent PCR and Q-RT-PCR amplification.

Authors:  Csaba Bödör; Otto Schmidt; Balázs Csernus; Hajnalka Rajnai; Béla Szende
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

2.  High expression of a cytokeratin-associated protein in many cancers.

Authors:  Kristi A Egland; Xiu Fen Liu; Stephen Squires; Satoshi Nagata; Yan-Gao Man; Tapan K Bera; Masanori Onda; James J Vincent; Robert L Strausberg; Byungkook Lee; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

3.  Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression.

Authors:  Yi-Hsuan Hsiao; Yan A Su; Horng-Der Tsai; Jeffrey T Mason; Ming-Chih Chou; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2010-08-08       Impact factor: 6.580

4.  Tumor-infiltrating immune cells: triggers for tumor capsule disruption and tumor progression?

Authors:  Bin Jiang; Jeffrey Mason; Anahid Jewett; Min-ling Liu; Wen Chen; Jun Qian; Yijiang Ding; Shuqing Ding; Min Ni; Xichen Zhang; Yan-gao Man
Journal:  Int J Med Sci       Date:  2013-03-05       Impact factor: 3.738

5.  Destructive impact of T-lymphocytes, NK and Mast cells on basal cell layers: implications for tumor invasion.

Authors:  Hongyan Yuan; Yi-Hsuan Hsiao; Yiyu Zhang; Jinlian Wang; Chao Yin; Rong Shen; Yiping Su
Journal:  BMC Cancer       Date:  2013-05-25       Impact factor: 4.430

6.  Failure to detect active virus replication in mast cells at various tissue sites of HIV patients by immunohistochemistry.

Authors:  Ann Marie Nelson; Aaron Auerbach; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2009-09-22       Impact factor: 6.580

7.  Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones?

Authors:  Xichen Zhang; Shahreyar Shar Hashemi; Morvarid Yousefi; Jinsong Ni; Qiuyue Wang; Ling Gao; Pengtao Gong; Chunling Gao; Joy Sheng; Jeffrey Mason; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2008-08-16       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.